Company Johnson & Johnson Deutsche Boerse AG

Equities

JNJ0

CA47817E1034

Pharmaceuticals

Delayed Deutsche Boerse AG 02:06:09 2024-05-14 EDT 5-day change 1st Jan Change
13.4 EUR +0.75% Intraday chart for Johnson & Johnson +1.52% -2.19%

Business Summary

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:

- pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.;

- medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;

- consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc.

At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25).

Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).

Number of employees: 131,900

Sales per Business

USD in Million2022Weight2023Weight Delta
Innovative Medicine
64.3 %
52,563 55.4 % 54,759 64.3 % +4.18%
MedTech
35.7 %
27,427 28.9 % 30,400 35.7 % +10.84%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
54.5 %
48,580 51.2 % 46,444 54.5 % -4.40%
Europe
24.0 %
23,449 24.7 % 20,410 24.0 % -12.96%
Asia-Pacific, Africa
16.2 %
16,789 17.7 % 13,756 16.2 % -18.07%
Western Hemisphere Excluding United States
5.3 %
6,125 6.5 % 4,549 5.3 % -25.73%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 88-12-31
Director of Finance/CFO 57 97-12-31
Chief Tech/Sci/R&D Officer 58 19-11-04
Chief Tech/Sci/R&D Officer - 22-12-30
Chief Tech/Sci/R&D Officer 74 06-12-31
Investor Relations Contact - 21-10-31
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal 47 18-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 70 19-04-24
Director/Board Member 72 14-06-18
Director/Board Member 70 09-10-21
Director/Board Member 64 19-12-04
Director/Board Member 60 13-10-14
Chief Executive Officer 61 88-12-31
Director/Board Member 58 22-02-14
Director/Board Member 59 11-29
Director/Board Member 62 19-12-04
Director/Board Member 63 20-12-02

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,119,799,183 2,404,498,937 ( 77.07 %) 713,120,000 ( 22.86 %) 77.07 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.500 %
228,938,504 9.500 % 33 613 M €
BlackRock Advisors LLC
6.048 %
145,731,837 6.048 % 21 396 M €
132,904,295 5.515 % 19 513 M €
Eaton Vance Management
1.729 %
41,659,479 1.729 % 6 116 M €
BlackRock Life Ltd.
1.555 %
37,465,814 1.555 % 5 501 M €
State Farm Investment Management Corp.
1.314 %
31,675,492 1.314 % 4 651 M €
JPMorgan Investment Management, Inc.
1.216 %
29,309,544 1.216 % 4 303 M €
Capital Research & Management Co. (International Investors)
1.203 %
28,985,676 1.203 % 4 256 M €
Wells Fargo Bank NA
1.140 %
27,462,743 1.140 % 4 032 M €
Norges Bank (13F)
1.078 %
25,977,042 1.078 % 3 814 M €
NameEquities%Valuation
BB Gestão de Recursos DTVM SA
0.000634 %
229,349 0.000634 % 2 M €
Itaú Unibanco SA
0.000458 %
165,787 0.000458 % 2 M €
Safra Asset Management Ltda.
0.000274 %
99,300 0.000274 % 958 879 €
Bram Bradesco Asset Management S/A DTVM
0.000230 %
83,250 0.000230 % 803 894 €
Caixa DTVM SA
0.000103 %
37,422 0.000103 % 361 361 €
XP Allocation Asset Management Ltda.
0.000038 %
13,915 0.000038 % 134 369 €
Warren Brasil Gestão e Administração e Recursos Ltda.
0.000024 %
8,663 0.000024 % 83 653 €
Western Asset Management Company DTVM Ltda.
0.000001 %
380 0.000001 % 3 669 €
Morgan Stanley Administradora de Carteiras SA
0.000000 %
51 0.000000 % 492 €

Holdings

NameEquities%Valuation
182,329,550 9.52% 3,467,908,041 $
810,170 0.51% 98,071,079 $
3,670,516 4.33% 78,549,042 $
2,449,183 4.20% 60,396,853 $
4,103,430 19.00% 59,048,358 $
166,812 0.44% 54,879,480 $
814,586 0.45% 36,183,910 $
5,623,816 11.93% 33,236,753 $
1,979,173 8.46% 31,646,976 $
6,641,064 10.34% 31,279,411 $

Company contact information

Johnson & Johnson

One Johnson & Johnson Plaza

08933, New Brunswick

+732 524 0400

http://www.jnj.com
address Johnson & Johnson(JNJ0)

Group companies

NameCategory and Sector
Medical Specialties
Pharmaceuticals: Major
Electronic Components
Medical Specialties
Pharmaceuticals: Major
Pharmaceuticals: Major
Household/Personal Care
Pharmaceuticals: Major
Medical Specialties

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
151.2 USD
Average target price
173.3 USD
Spread / Average Target
+14.58%
Consensus
  1. Stock Market
  2. Equities
  3. JNJ Stock
  4. JNJ0 Stock
  5. Company Johnson & Johnson
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW